Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Sebastian

Showing results (131-140 of 149) with videos related to

Pageof 15
Sort By:
Molecular Cancer Therapeutics|October 7, 2025
Ubiquitination of oncogenic mutant p53 via attenuation of ribosome biogenesis machinery effectively inhibits pancreatic tumor growthMudassier Ahmad, Sahir Sultan Alvi, Haider Ahsan, et al.
Iscience|June 22, 2026
SynCAR platform for capturing neuronal synaptic proteopathic seedsRebecca M Sebastian, Robert Kupp, Dhaval Nanavati, et al.
Cellular and Molecular Gastroenterology and Hepatology|June 1, 2021
A Novel Noninvasive Method Based on Salivary Inflammatory Biomarkers for the Screening of Celiac DiseaseM Sebastian-delaCruz, A Olazagoitia-Garmendia, A Huerta Madrigal, et al.
Heart, Lung & Circulation|February 14, 2006
The foundation and launch of the Melbourne Interventional Group: a collaborative interventional cardiology projectA E Ajani, G Szto, S J Duffy, et al.
Nature|January 4, 2013
Flows of gas through a protoplanetary gapSimon Casassus, Gerrit van der Plas, M Sebastian Perez, et al.
Archives of Dermatological Research|February 22, 2012
German S3-guidelines on the treatment of psoriasis vulgaris (short version)A Nast, W H Boehncke, U Mrowietz, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|September 8, 2016
Effect of dose adjustment on the safety and efficacy of afatinib for EGFR mutation-positive lung adenocarcinoma: post hoc analyses of the randomized LUX-Lung 3 and 6 trialsJ C-H Yang, L V Sequist, C Zhou, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|August 31, 2020
Osimertinib versus platinum-pemetrexed for patients with EGFR T790M advanced NSCLC and progression on a prior EGFR-tyrosine kinase inhibitor: AURA3 overall survival analysisV A Papadimitrakopoulou, T S Mok, J-Y Han, et al.
Gastroenterology|March 20, 2019
PPARD and Interferon Gamma Promote Transformation of Gastric Progenitor Cells and Tumorigenesis in MiceXiangsheng Zuo, Yasunori Deguchi, Weiguo Xu, et al.
Archives of Dermatological Research|May 15, 2007
German evidence-based guidelines for the treatment of Psoriasis vulgaris (short version)A Nast, I Kopp, M Augustin, et al.
Pageof 15

Showing results (131-140 of 149) with videos related to

Sort By:
Pageof 15
Molecular Cancer Therapeutics|October 7, 2025
Ubiquitination of oncogenic mutant p53 via attenuation of ribosome biogenesis machinery effectively inhibits pancreatic tumor growthMudassier Ahmad, Sahir Sultan Alvi, Haider Ahsan, et al.
Iscience|June 22, 2026
SynCAR platform for capturing neuronal synaptic proteopathic seedsRebecca M Sebastian, Robert Kupp, Dhaval Nanavati, et al.
Cellular and Molecular Gastroenterology and Hepatology|June 1, 2021
A Novel Noninvasive Method Based on Salivary Inflammatory Biomarkers for the Screening of Celiac DiseaseM Sebastian-delaCruz, A Olazagoitia-Garmendia, A Huerta Madrigal, et al.
Heart, Lung & Circulation|February 14, 2006
The foundation and launch of the Melbourne Interventional Group: a collaborative interventional cardiology projectA E Ajani, G Szto, S J Duffy, et al.
Nature|January 4, 2013
Flows of gas through a protoplanetary gapSimon Casassus, Gerrit van der Plas, M Sebastian Perez, et al.
Archives of Dermatological Research|February 22, 2012
German S3-guidelines on the treatment of psoriasis vulgaris (short version)A Nast, W H Boehncke, U Mrowietz, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|September 8, 2016
Effect of dose adjustment on the safety and efficacy of afatinib for EGFR mutation-positive lung adenocarcinoma: post hoc analyses of the randomized LUX-Lung 3 and 6 trialsJ C-H Yang, L V Sequist, C Zhou, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|August 31, 2020
Osimertinib versus platinum-pemetrexed for patients with EGFR T790M advanced NSCLC and progression on a prior EGFR-tyrosine kinase inhibitor: AURA3 overall survival analysisV A Papadimitrakopoulou, T S Mok, J-Y Han, et al.
Gastroenterology|March 20, 2019
PPARD and Interferon Gamma Promote Transformation of Gastric Progenitor Cells and Tumorigenesis in MiceXiangsheng Zuo, Yasunori Deguchi, Weiguo Xu, et al.
Archives of Dermatological Research|May 15, 2007
German evidence-based guidelines for the treatment of Psoriasis vulgaris (short version)A Nast, I Kopp, M Augustin, et al.
Pageof 15